Skip to main content

Table 2 Multivariate analysis of platelet reactivity in the overall population

From: Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study

 

Coefficient (SE)

t

95 % CI

Exponentiated coefficient*

p-value

Male gender

0.04 (0.09)

0.24

−0.13 to 0.21

1.04

0.6

Current smoking

−0.15 (0.12)

1.48

−0.39 to 0.09

0.86

0.2

-Insulin-treated diabetes mellitus (vs non-diabetic status)

0.26 (0.11)

6.03

0.053 to 0.47

1.30

0.01

-Non insulin-treated diabetes mellitus (vs non-diabetic status)

0.04 (0.07)

0.34

−0.10 to 0.18

1.04

0.6

Ticagrelor (vs prasugrel)

−0.88 (0.06)

217.9

−0.99 to −0.76

0.42

<0.001

Age

0.001 (0.003)

0.08

−0.005 to 0.007

1.001

0.8

Body mass index

0.006 (0.007)

0.88

−0.007 to 0.019

1.006

0.4

Creatinine clearance < 60 ml/min

0.10 (0.09)

1.09

−0.09 to 0.29

1.1

0.3

Statin

0.24 (0.18)

1.79

−0.11 to 0.60

1.27

0.2

Proton pump inhibitor

0.11 (0.12)

0.75

−0.14 to 0.35

1.11

0.4

Hypertension

0.04 (0.06)

0.41

−0.08 to 0.16

1.04

0.5

STEMI at admission

−0.11 (0.06)

3.10

−0.23 to 0.01

0.90

0.08

  1. SE = standard error, CI = confidence interval, STEMI = ST-segment elevation myocardial infarction. *Exponentiated coefficient = e^Coefficient is the factor by which PR on the original scale is multiplied